Cargando…
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 Infection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853913/ http://dx.doi.org/10.1007/s40278-022-10330-4 |
Ejemplares similares
-
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 pulmonary infection: case report
Publicado: (2021) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2020) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2021) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: Pneumatosis intestinalis: case report
Publicado: (2021) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 and Pneumocystis jirovecii pneumonia: case report
Publicado: (2022)